Cargando…
Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis
Depression is very common after stroke, causing multiple sequelae. We aimed to explore the efficacy of escitalopram for poststroke depression (PSD). PubMed, Embase, Scopus, Cochrane Central Register of Controlled Trials, Clinical trials. gov, Wan fang Data (Chinese), VIP (Chinese) and CNKI (Chinese)...
Autores principales: | Feng, Rong-fang, Ma, Rui, Wang, Peng, Ji, Xu, Zhang, Zhen-xiang, Li, Meng-meng, Jiao, Jia-wei, Guo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885641/ https://www.ncbi.nlm.nih.gov/pubmed/35228575 http://dx.doi.org/10.1038/s41598-022-05560-w |
Ejemplares similares
-
Publisher Correction: Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis
por: Feng, Rong-fang, et al.
Publicado: (2022) -
Efficacy of escitalopram oxalate for patients with post-stroke depression
por: Xu, Ji-hua, et al.
Publicado: (2018) -
Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021) -
Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022) -
Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis
por: Feng, Rongfang, et al.
Publicado: (2018)